---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-283187"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:17:01.671940+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics schedules 2024 annual meeting for Feb 24, 2025; sets proposal deadline Dec 30

## Summary
- Annual meeting set for February 24, 2025; deadline for stockholder proposals and director nominations is December 30, 2024.
- Stockholders must comply with bylaw informational requirements; notice to secretary Joel Sussman at Malvern, PA address.
- Universal proxy rule compliance requires additional notice for solicitations in support of non-company nominees by same deadline (Dec 30).
- Proposals for inclusion in proxy materials under Rule 14a-8 must be received by Dec 30 to be considered timely.

## SEC filing metadata
- accession: 0001193125-24-283187
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312524283187/0001193125-24-283187-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312524283187/d918483d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-283187
- JSON: https://secwatch.observer/filing/0001193125-24-283187.json
- Plain text: https://secwatch.observer/filing/0001193125-24-283187.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.